Showing results (11-20 of 17) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Hematological Oncology|October 17, 2022
Circulating cell-free DNA for target quantification in hematologic malignancies: Validation of a protocol to overcome pre-analytical biasesRoberta Soscia, Irene Della Starza, Lucia Anna De Novi, et al.Blood Advances|January 10, 2024
Prophylactic maintenance with venetoclax/azacitidine after reduced-intensity conditioning allogeneic transplant for high-risk MDS and AMLJacqueline S Garcia, Haesook T Kim, H Moses Murdock, et al.The Oncologist|April 21, 2018
Lenalidomide in Pretreated Mantle Cell Lymphoma Patients: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice (the Lenamant Study)Vittorio Stefoni, Cinzia Pellegrini, Alessandro Broccoli, et al.Journal of Hematology & Oncology|February 13, 2025
First-in-human evaluation of memory-like NK cells with an IL-15 super-agonist and CTLA-4 blockade in advanced head and neck cancerRoman M Shapiro, Michal Sheffer, Matthew A Booker, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 30, 2026
Randomized, Placebo-Controlled Trial of B-Cell Depletion for Prevention of Corticosteroid-Requiring Chronic Graft-Versus-Host DiseaseCorey Cutler, Haesook T Kim, Hassan El Banna, et al.Haematologica|May 30, 2020
Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913Sabina Chiaretti, Monica Messina, Irene Della Starza, et al.The Journal of Clinical Investigation|June 25, 2024
Oncogene-induced TIM-3 ligand expression dictates susceptibility to anti-TIM-3 therapy in miceNana Talvard-Balland, Lukas M Braun, Karen O Dixon, et al.Pageof 2